• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAmgen

Amgen

ConferencesAI is in the early stages of upending the drug discovery and development process, but there will still need to be a ‘lab in the loop’
By Sage LazzaroDecember 14, 2023
HealthHow Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By Arthur Allen and KFF Health NewsApril 13, 2023
MagazineBig Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?
By Geoff ColvinApril 8, 2021
NewslettersInclusion in the Dow does not guarantee a bump to your share price
By Katherine Dunn and Alan MurrayAugust 27, 2020
NewslettersCan the Dow’s Big Tech makeover finally push the blue chip index above 30,000?
By Bernhard WarnerAugust 25, 2020
FinanceSalesforce, Amgen, and Honeywell Int’l will join Dow Jones Industrial Average
By Andrew NuscaAugust 24, 2020
Brainstorm Health 2020-Robert Bradway
ConferencesAmgen CEO is ‘optimistic’ about COVID-19 clinical trials
By Aaron PressmanJuly 7, 2020
Amgen BeiGene China Bitoech
NewslettersU.S. Biotech Amgen Strikes Major Deal to Expand China Presence
By Sy MukherjeeOctober 31, 2019
Health3 Drug Giants Win a Legal Victory Against Trump—For Now: Brainstorm Health
By Sy MukherjeeJuly 9, 2019
Drug price TV ad lawsuit
HealthBig Drug Makers Sue to Block Mandatory Price Disclosures in TV Ads: Brainstorm Health
By Sy MukherjeeJune 14, 2019
HealthThe FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By David MeyerMay 18, 2018
BioGen Alzheimers
HealthWe’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?
By Sy MukherjeeNovember 2, 2017
An Amgen sign is seen at the company's office in South San Francisco
HealthAmgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?
By Sy MukherjeeSeptember 15, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Rise Amid Stronger Job Gains Boost Optimism On Economy
HealthThis Biotech’s Stock Plunged 24% After the FDA Rejected Its Amgen Drug Copycat
By Sy MukherjeeJune 12, 2017
Elektrocardiogram
HealthA Heart Attack-Prevention Drug Disappoints…Wall Street
By Clifton LeafMarch 17, 2017
1
  • 1
  • 2
2
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.